Tamoxifen
Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Tamoxifen and local guidelines before prescribing.
Mechanism
Selective oestrogen receptor modulator.
Uses
ER-positive breast cancer treatment and prevention.
Dosing
- Retinal toxicity - dose no more than 5 mg/kg/day; baseline eye check within 1 year and annual retinal screening after 5 years of use (earlier - after 1 year - with risk factors such as kidney impairment, tamoxifen or higher doses) (RCOphth).
Rheumatology: assessment, investigations and drugs - Hydroxychloroquine (and chloroquine) | Retinal toxicity ("bull's-eye" maculopathy) — irreversible; risk with dose over 5 mg/kg/day (actual body weight), long duration, renal impairment, tamoxifen — annual screening (OCT and fields) after 5 years of use (after 1 year if additional risk factors — RCOphth 2020)
Ophthalmology: Anatomy Physiology and Pharmacology - Hydroxychloroquine | Retinal toxicity (bull's-eye maculopathy, permanent). Keep dose at 5 mg/kg/day or less (actual body weight). RCOphth : yearly screening (OCT and fields) after 5 years , or after 1 year if extra risk (eGFR under 60, tamoxifen, higher doses).
Ophthalmology: Neuro-ophthalmology
Side effects
Hot flushes, VTE, endometrial hyperplasia and cancer, visual disturbance.
Interactions
CYP2D6 inhibitors (paroxetine, fluoxetine) reduce activation; warfarin effect rises.
Contraindications and cautions
VTE history, endometrial cancer risk
Monitoring
Gynaecology review, bleeding
Pregnancy and breastfeeding
Contraindicated
Renal and hepatic impairment
Caution in liver disease
Overdose and reversal
Supportive
Special advice
Report abnormal vaginal bleeding; avoid in VTE history; review duration with oncology.
More from the textbook: uses, cautions and other points
- Management: Corticosteroids, tamoxifen or rituximab; surgery to relieve compression.
Endocrinology: Thyroid disease - Drugs - oral oestrogens, retinoids, thiazides, beta-blockers, steroids, antipsychotics, antiretrovirals, tamoxifen.
Endocrinology: Lipids and obesity - SSRIs or SNRIs - avoid paroxetine and fluoxetine with tamoxifen.
Endocrinology: Reproductive - Tamoxifen (specialist) for painful, recent gynaecomastia.
Endocrinology: Reproductive - Fatty liver | Amiodarone, methotrexate, steroids, tamoxifen, valproate (microvesicular), tetracyclines (IV)
Gastroenterology: Anatomy Physiology Pharmacology - Fatty liver | Amiodarone, methotrexate, steroids, tamoxifen, valproate, tetracyclines
Gastroenterology: Liver disease
Where it is discussed in the book
- Endocrinology: Thyroid disease (1 mention)
- Endocrinology: Lipids and obesity (1 mention)
- Endocrinology: Reproductive (2 mentions)
- Gastroenterology: Anatomy Physiology Pharmacology (1 mention)
- Gastroenterology: Liver disease (1 mention)
- Haematology: Anatomy Physiology and Pharmacology (1 mention)
- Haematology: History and Examination (1 mention)
- Oncology: Principles (5 mentions)
- Oncology: Breast and Gynae Cancers (4 mentions)
- Gynaecology: Menstrual Disorders (5 mentions)
- Gynaecology: Fertility Contraception Menopause (2 mentions)
- Rheumatology: assessment, investigations and drugs (1 mention)
- Ophthalmology: Anatomy Physiology and Pharmacology (1 mention)
- Ophthalmology: Neuro-ophthalmology (1 mention)
- Surgey: Breast and endocrine surgery (3 mentions)
- Clinical Genetics: Cancer genetics and inherited cardiovascular conditions (1 mention)
- Clinical Genetics: Prenatal and newborn screening, pharmacogenomics and ethics (2 mentions)
- Histology: Organ-system histology (1 mention)